Biopharma Marketing Outlook 2027

It's the second edition of the outlook Digitalya publishes with Magnolia. This year it looks at how pharma can use AI in three value-driving areas:

• Being found in AI answers

• AI-powered search on the HCP portal

• Intent-based relevance.

It's built on interviews with nine specialists in pharma marketing, search, HCP portals, and AI governance, supported by named third-party research.

The outlook identifies six.

1. HCPs now search in full questions, which Google is more likely to answer itself.

2. GEO builds on SEO, and pharma's regulatory rigor gives it a head start on the trust signals

3. AI systems look for. The HCP login wall is the biggest constraint on being found.

4. AI search on the portal pays off when it returns time to clinicians and shows teams what HCPs ask.

5. Relevance works better than heavy personalization when there are only a few touchpoints per doctor.

6. And approval remains the real bottleneck for customer-facing AI.

Marketing, commercial, and digital leads at mid-size and large pharma companies, especially the teams that own HCP websites and portals, search and content, or omnichannel engagement.

It's also useful for anyone who needs AI projects to get through medical, legal, and regulatory review.

Generative engine optimization (GEO) is the work of making content findable, readable, and citable by AI systems such as ChatGPT, Claude, Perplexity, and Google's AI Overviews.

The specialists in the outlook describe it as an evolution of SEO: technical foundations, structured data, demonstrable authority, and relevant links all carry over.

For pharma, the new work starts with two questions: can AI crawlers read your content at all, and what sits behind the HCP login where no AI system can reach it?

We interviewed specialists across pharma marketing and digital operations, search and content agencies, and AI technology, and supported the interviews with third-party research that is cited and linked in the text.

Contributors weren't asked to agree, so where they disagree, the outlook reports both sides.

Some contributors are partners of Digitalya or Magnolia, and they describe their product capabilities in their own words.

This edition is weighted toward HCP engagement.

The 2025 edition covered modular platforms, direct-to-stakeholder strategies, and AI's role in delivering fast, compliant content.

The 2027 edition is built on expert interviews and focuses on three areas where AI already creates value in HCP engagement, plus the approval process that decides whether any of it reaches customers.

Yes. If you'd like to discuss how the findings apply to your HCP portal or website, contact us, and Alex Jijie or a team member will get back to you.